Clin Chem Lab Med. 2013 Oct;51(10):2029-35. doi: 10.1515/cclm-2013-0109.
Glycogen phosphorylase BB (GPBB) is released from cardiac cells during myocyte damage. Previous studies have shown contradictory results regarding the relation of enzyme release and reversible myocardial ischemia. The aim of this study was to determine the plasma kinetics of GPBB as a response to the exercise stress echocardiographic test (ESET), and to define the relationship between myocardial ischemia and enzyme plasma concentrations.
We studied 46 consecutive patients undergoing ESET, with recent coronary angiography. In all patients, a submaximal stress echo test according to Bruce protocol was performed. Concentration of GPBB was measured in peripheral blood that was sampled 5 min before and 10, 30 and 60 min after ESET.
There was significant increase of GPBB concentration after the test (p=0.021). Significant increase was detected 30 min (34.9% increase, p=0.021) and 60 min (34.5% increase, p=0.016) after ESET. There was no significant effect of myocardial ischemia on GPBB concentrations (p=0.126), and no significant interaction between sampling intervals and myocardial ischemia, suggesting a similar release profile of GPBB in ischemic and non-ischemic conditions (p=0.558). Patients in whom ESET was terminated later (stages 4 or 5 of standard Bruce protocol; n=13) had higher GPBB concentrations than patients who terminated ESET earlier (stages 1, 2 or 3; n=33) (p=0.049). Baseline GPBB concentration was not correlated to any of the patients' demographic, clinical and hemodynamic characteristics.
GPBB plasma concentration increases after ESET, and it is not related to inducible myocardial ischemia. However, it seems that GPBB release during ESET might be related to exercise load/duration.
肌细胞损伤时,糖原磷酸化酶 BB(GPBB)从心肌细胞中释放出来。先前的研究表明,酶的释放与可逆性心肌缺血之间的关系存在矛盾。本研究旨在确定 GPBB 作为运动超声心动图试验(ESET)应激反应的血浆动力学,并定义心肌缺血与酶血浆浓度之间的关系。
我们研究了 46 例连续进行 ESET 的患者,他们最近进行了冠状动脉造影。在所有患者中,根据 Bruce 方案进行了亚最大应激超声心动图试验。在 ESET 前 5 分钟和 ESET 后 10、30 和 60 分钟采集外周血样,测量 GPBB 浓度。
试验后 GPBB 浓度显著升高(p=0.021)。ESET 后 30 分钟(增加 34.9%,p=0.021)和 60 分钟(增加 34.5%,p=0.016)检测到显著增加。心肌缺血对 GPBB 浓度无显著影响(p=0.126),采样间隔和心肌缺血之间无显著相互作用,提示在缺血和非缺血条件下 GPBB 释放具有相似的特征(p=0.558)。ESET 结束较晚(标准 Bruce 方案的第 4 或 5 阶段;n=13)的患者 GPBB 浓度高于 ESET 较早结束的患者(第 1、2 或 3 阶段;n=33)(p=0.049)。GPBB 基础浓度与患者的任何人口统计学、临床和血液动力学特征均无相关性。
ESET 后 GPBB 血浆浓度升高,与诱导性心肌缺血无关。然而,ESET 期间 GPBB 的释放似乎与运动负荷/持续时间有关。